Price T Rowe Associates Inc Recursion Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 88,115 shares of RXRX stock, worth $543,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,115

Previous 62,065 41.97%

Holding current value

$543,669

Previous $619,000 6.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $191,467 - $261,802	26,050 Added 41.97%	88,115 $661,000
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $50,224 - $85,375	5,501 Added 9.73%	62,065 $619,000
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $18,268 - $38,725	3,589 Added 6.77%	56,564 $558,000
Q3 2023 Nov 14, 2023	SELL	$6.59 - $15.86 $157,178 - $378,276	-23,851 Reduced 31.05%	52,975 $406,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $9,270 - $20,208	2,033 Added 2.72%	76,826 $574,000
Q1 2023 May 15, 2023	SELL	$6.42 - $9.64 $7,228 - $10,854	-1,126 Reduced 1.48%	74,793 $499,000
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $284,345 - $504,355	39,713 Added 109.69%	75,919 $585,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $104,968 - $182,321	13,406 Added 58.8%	36,206 $386,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.26 $2.72 Million - $4.99 Million	-539,390 Reduced 95.94%	22,800 $186,000
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $1.82 Million - $5.33 Million	-295,383 Reduced 34.44%	562,190 $4.03 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $4.47 Million - $6.05 Million	276,903 Added 47.69%	857,573 $14.7 Million
Q3 2021 Nov 15, 2021	SELL	$19.03 - $41.33 $45,957 - $99,811	-2,415 Reduced 0.41%	580,670 $13.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $10.5 Million - $21.8 Million	583,085 New	583,085 $21.3 Million

Others Institutions Holding RXRX

# of Institutions

285

Shares Held

236M

Call Options Held

972K

Put Options Held

2.4M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.11B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Recursion Pharmaceuticals, Inc. Transaction History